Adverse Event reporting information can be found in footer

Request a Meeting

Next Event in:

Days

Hours

Minutes

Seconds

This meeting is organised and fully funded by Ferring Pharmaceuticals Ltd
Thu 26th Sep 2019 - Fri 27th Sep 2019

Crown Plaza Hotel, Fieldhouse Lane, Marlow, SL7 1GJ

IBD Doctors National Meeting 2019

"IBD Treatment: 2020 & Beyond"

 

The Scientific Faculty and Ferring Pharmaceuticals are delighted to invite you to IBD treatment: 2020 and beyond. The event will take place from the evening of 26th and 27th September at the Crowne Plaza Hotel, Fieldhouse Lane, Marlow, SL7 1GJ.

Commissioned and sponsored by Ferring Pharmaceuticals. Ferring Pharmaceuticals has not been involved in the creation & development of the educational content for this meeting.

Click on the icons in the Agenda below to access speaker presentation materials.

– Presentation Video
– Presentation Audio
– Speaker Slides

Agenda Download

September 25, 2019

7:00 pm - 7:50 pm
Registration and pre-dinner drinks
Session 1
7:50 pm - 8:00 pm
Welcome and introduction
8:00 pm -
Dinner and Interactive IBD Challenge

September 26, 2019

8:00 am - 8:30 am
Registration
8:30 am - 8:40 am
Chair's Introduction
Session 2
Challenges in 2020
8:40 am - 9:00 am
Managing the mild IBD patient
Dr Barney Hawthorne
agenda icon agenda popup icon
9:00 am - 9:30 am
When it starts to go wrong making the most of TDM (TNF and beyond) with Q&A
Dr Nick Kennedy
agenda icon agenda popup icon
9:30 am - 10:00 am
Managing the patient with pouchitis
Professor Ailsa Hart
10:00 am - 10:30 am
Managing the patient with peri-anal disease with Q&A
Dr Tim Raine
agenda icon agenda popup icon
10:30 am - 11:00 am
Coffee and check out
Session 3
Horizon scanning
11:00 am - 11:20 am
Emerging therapies targeting leucocyte trafficking
Dr Chris Lamb
11:20 am - 11:50 am
Emerging therapies targeting cytokines and cytokine signalling pathways with Q&A
Professor James Lindsay
agenda icon agenda popup icon
11:50 am - 12:05 pm
Cell based therapies
Dr Nick Powell
agenda icon agenda popup icon
12:05 pm - 12:30 pm
Faecal Microbiota Transplant (FMT) with Q&A
Professor Tariq Iqbal
agenda icon agenda popup icon
12:30 pm - 12:50 pm
Lessons from rheumatology: how to make rational decisions in a multi-drug era
Dr Frances Humby
agenda icon agenda popup icon
12:50 pm - 1:00 pm
Q&A
1:00 pm - 1:45 pm
Lunch
Session 4
2020: Addressing patient needs
1:45 pm - 2:00 pm
What a patient wants from their IBD Team in 2020: a patients’ perspective
Ms Rosie Campbell
agenda icon agenda popup icon
2:00 pm - 2:15 pm
Transforming the way we deliver care in 2020: Digital Health in IBD
Dr Gareth Parkes
agenda icon agenda popup icon
2:15 pm - 2:30 pm
The role of the psychologist in the IBD team: ways to utilise psychology within services to address patient needs
Dr Fiona Eldridge
agenda icon agenda popup icon
2:30 pm - 2:45 pm
Quality counts: how to best capture patient experience in IBD
Dr Alissa Walsh
agenda icon agenda popup icon
2:45 pm - 3:00 pm
Q&A
3:00 pm - 3:30 pm
The future of diet in the management of IBD: what is likely to change in 2020 & beyond?
Professor Kevin Whelan
3:30 pm - 3:40 pm
Q&A
3:40 pm - 3:45 pm
Faculty Wrap Up
3:45 pm -
Depart - coffee provided to take away

Speakers

Dr Nick Kennedy

Gastrointestinal and Liver Services, Royal Devon and Exeter NHS Foundation Trust, Devon

Dr Barney Hawthorne

Consultant Specialist in IBD and intestinal failure, University Hospital of Wales, Cardiff

Professor Ailsa Hart

Consultant Gastroenterologist, St Mark’s Hospital, London

Dr Chris Lamb

Consultant Gastroenterologist, The Royal Victoria Hospital, Newcastle

Professor James Lindsay

Professor of IBD and Consultant Gastroenterologist, Barts Health NHS Trust, London

Dr Nick Powell

Consultant Gastroenterologist, King’s College and Guy’s & St Thomas’ NHS Foundation Trust, London

Professor Tariq Iqbal

Consultant Gastroenterologist, Queen Elizabeth Hospital, Birmingham

Dr Frances Humby

Consultant in Rheumatology, Barts Health NHS Trust, London

Dr Gareth Parkes

Consultant Gastroenterologist, Royal London Hospital, London

Dr Fiona Eldridge

Principal Clinical Psychologist, Addenbrooke’s Hospital, Cambridge

Professor Kevin Whelan

Professor of Dietetics and Head of Department of Nutritional Sciences, King’s College, London

Dr Tim Raine

Consultant Gastroenterologist, Addenbrooke’s Hospital, Cambridge

Ms Rosie Campbell

IBD Patient

Dr Alissa Walsh

Consultant Gastroenterologist, Translational Gastroenterology Unit, Nuffield Department of Medicine, Oxford

Meet the FacultyClick faculty images for biographies

Dr Gareth Parkes

Gareth trained at Cambridge, Bart’s & the London and studied for a PhD at King’s College London, examining the role of the gut bacteria in the development of irritable bowel syndrome. He now works as a Consultant Gastroenterologist at the Royal London Hospital where he is a core member of the IBD team. His interests include Irritable Bowel Syndrome (IBS), Crohn’s disease, Ulcerative Colitis, probiotics and low FODMAP diets in IBS as well as indigestion and heartburn. Gareth sits on the British Society of Gastroenterology IBD committee, has a number of publications in the field of IBS and IBD and reviews papers for Alimentary Pharmacology & Therapeutics (APT), Neurogastromotility and the Annals of Gastroenterology. He is actively involved as a chief investigator in commercial clinical trials and has developed the UK’s first mobile phone App for patients with IBD ‐ ‘My IBD Care’.

Dr Chris Lamb

Chris Lamb is an academic gastroenterologist working as an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals NHS Foundation Trust and a Clinical Intermediate Fellow at Newcastle University. A former NIHR Clinical Lecturer and previous Wellcome Trust Clinical Fellow in Translational Medicine and Therapeutics he has a clinical and research specialist interest in inflammatory bowel disease.

Chris leads a mucosal immunology research programme that studies biological signatures of inflammation aiming to inform existing treatment stratification, the development of novel, or repurposing of existing therapies, and innovative clinical trial design to benefit patients through contributing to precision medicine strategies. In addition he has an interest in evidence synthesis and for the last 3 years along with a multidisciplinary group of UK IBD clinicians and patients he has led the development of the British Society of Gastroenterology (BSG) guidelines on management of IBD in adults. Chris is a previous recipient of the award Young Gastroenterologist of the Year: Emerging Leader from the BSG, and was previously awarded the BSG President’s medal by Sir Ian Gilmore. He is a current member of the IBD Section of the BSG and has previously Chaired the Trainees Section Committee, and been a member of the Training Committee, Education Committee and Council of the BSG.

Dr Tim Raine

Tim Raine is a consultant gastroenterologist and clinical lead for IBD at Addenbrooke’s Hospital, Cambridge, UK. Tim is a member of the ECCO (European Crohn’s and Colitis Organisation) guidelines committee, and an author and group leader on several current ECCO guidelines. He serves on the British Society of Gastroenterology (BSG) IBD Clinical Research Group and was awarded BSG Young Gastroenterologist of the Year 2016. Tim has an interest in clinical trials and is lead investigator of several studies including the major UK IASO trial in acute-severe colitis. His research, funded by the Wellcome Trust, CCFA, OpenTargets and the National Institute for Health Research, focuses on regulation of the gastrointestinal immune system. Tim is an honorary faculty member of the Wellcome Trust Sanger Centre, UK.

Gareth trained at Cambridge, Bart’s & the London and studied for a PhD at King’s College London, examining the role of the gut bacteria in the development of irritable bowel syndrome. He now works as a Consultant Gastroenterologist at the Royal London Hospital where he is a core member of the IBD team. His interests include Irritable Bowel Syndrome (IBS), Crohn’s disease, Ulcerative Colitis, probiotics and low FODMAP diets in IBS as well as indigestion and heartburn. Gareth sits on the British Society of Gastroenterology IBD committee, has a number of publications in the field of IBS and IBD and reviews papers for Alimentary Pharmacology & Therapeutics (APT), Neurogastromotility and the Annals of Gastroenterology. He is actively involved as a chief investigator in commercial clinical trials and has developed the UK’s first mobile phone App for patients with IBD ‐ ‘My IBD Care’.

Chris Lamb is an academic gastroenterologist working as an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals NHS Foundation Trust and a Clinical Intermediate Fellow at Newcastle University. A former NIHR Clinical Lecturer and previous Wellcome Trust Clinical Fellow in Translational Medicine and Therapeutics he has a clinical and research specialist interest in inflammatory bowel disease.

Chris leads a mucosal immunology research programme that studies biological signatures of inflammation aiming to inform existing treatment stratification, the development of novel, or repurposing of existing therapies, and innovative clinical trial design to benefit patients through contributing to precision medicine strategies. In addition he has an interest in evidence synthesis and for the last 3 years along with a multidisciplinary group of UK IBD clinicians and patients he has led the development of the British Society of Gastroenterology (BSG) guidelines on management of IBD in adults. Chris is a previous recipient of the award Young Gastroenterologist of the Year: Emerging Leader from the BSG, and was previously awarded the BSG President’s medal by Sir Ian Gilmore. He is a current member of the IBD Section of the BSG and has previously Chaired the Trainees Section Committee, and been a member of the Training Committee, Education Committee and Council of the BSG.

Tim Raine is a consultant gastroenterologist and clinical lead for IBD at Addenbrooke’s Hospital, Cambridge, UK. Tim is a member of the ECCO (European Crohn’s and Colitis Organisation) guidelines committee, and an author and group leader on several current ECCO guidelines. He serves on the British Society of Gastroenterology (BSG) IBD Clinical Research Group and was awarded BSG Young Gastroenterologist of the Year 2016. Tim has an interest in clinical trials and is lead investigator of several studies including the major UK IASO trial in acute-severe colitis. His research, funded by the Wellcome Trust, CCFA, OpenTargets and the National Institute for Health Research, focuses on regulation of the gastrointestinal immune system. Tim is an honorary faculty member of the Wellcome Trust Sanger Centre, UK.

Meet the SpeakersClick the speaker for their biography

Dr Nick Kennedy

Dr Nick Kennedy is a Consultant Gastroenterologist at the Royal Devon and Exeter and Honorary Clinical Senior Lecturer at the University of Exeter. His clinical and research interests are in inflammatory bowel disease (Crohn’s disease and ulcerative colitis), and he is driven to improve the diagnosis and treatment of these chronic inflammatory conditions. He has experience in co-ordinating large multi-site projects to obtain clinical data and biological samples from IBD patients and skills in managing complex clinical and molecular datasets. He has a particular interest in understanding treatment response in IBD. He is a member of the UK and international IBD genetics consortia, sits on the British Society of Gastroenterology (BSG) IBD clinical research group and is one of the group leaders within the BSG IBD guidelines group. He is also an associate editor of Alimentary Pharmacology & Therapeutics.

Dr Barney Hawthorne

Consultant Specialist in IBD and intestinal failure, University Hospital of Wales, Cardiff ‐ Dr Hawthorne studied medicine at Queens’ College Cambridge, and went on to do his clinical training at the University of Oxford, qualifying in 1983. After doing an MD in Nottingham with Chris Hawkey, he took up a consultant post in Cardiff in 1995. His clinical interests are inflammatory bowel disease and intestinal failure. As well as developing the IBD services in Cardiff, he established and led the Cardiff Intestinal Failure service until 2017.
He is ex-chair of the BSG IBD section (2015-2018), led the writing of the BSG IBD guidelines (2019), and is chair of the Medical Research Grants committee for Crohn’s Colitis UK. He is a member of the IBD UK committee and has been involved in development of the UK IBD Standards 2019. He also sits on the IBD Wales committee. He is a director and board member of the IBD Registry co., representing the BSG. His research interests include clinical trials of immunosuppressive therapy in IBD, and the natural history of inflammatory bowel disease.

Professor Ailsa Hart

Professor Ailsa Hart is Consultant Gastroenterologist, St Mark’s Hospital and Sub-Dean of St Mark’s Hospital Academic Institute. She studied at Oxford University and was awarded a First Class Honours Degree. She achieved her PhD with Imperial College, funded by a Wellcome Trust Fellowship. She has published 2 books, over 200 papers, reviews and book chapters & supervised/ co-supervised over 20 higher degree students. She is currently on the Governing Board of the European Crohn’s and Colitis Organisation; is on the IBD Clinical Research Group Committee for the BSG; UK Patient and Public Involvement Lead for Gastroenterology; and on the Research Committee for the Crohn’s and Colitis UK charity.

Professor James Lindsay

James Lindsay is the Professor of Inflammatory Bowel Disease at Barts and the London School of Medicine and Dentistry, Queen Mary University of London and a Consultant Gastroenterologist at Barts Health NHS Trust. Along with a full multidisciplinary team he runs the adolescent and adult IBD service at The Royal London Hospital.
He is the Education Officer and a member of the Governing Board of the European Crohn’s and Colitis Organisation (ECCO). He is also the ECCO e-learning ambassador and past chair of the ECCO Education Committee. He has chaired working groups for the ECCO consensus on the management of Crohn’s disease and ulcerative colitis. He is the British Society of Gastroenterology (BSG) national societies representative to United European Gastroenterology and is a member of the International Organisation of IBD (IOIBD)
Professor Lindsay serves on the BSG IBD Clinical Trials Steering Group and is Chief Investigator for a series of investigator-led and commercial clinical trials in IBD. He leads the NIHR funded ASTIClite trial which will assess the efficacy, safety and mechanism of action of low intensity autologous stem cell transplantation in patients with refractory Crohn’s disease. In addition, he leads a program of translational science research.

Dr Nick Kennedy is a Consultant Gastroenterologist at the Royal Devon and Exeter and Honorary Clinical Senior Lecturer at the University of Exeter. His clinical and research interests are in inflammatory bowel disease (Crohn’s disease and ulcerative colitis), and he is driven to improve the diagnosis and treatment of these chronic inflammatory conditions. He has experience in co-ordinating large multi-site projects to obtain clinical data and biological samples from IBD patients and skills in managing complex clinical and molecular datasets. He has a particular interest in understanding treatment response in IBD. He is a member of the UK and international IBD genetics consortia, sits on the British Society of Gastroenterology (BSG) IBD clinical research group and is one of the group leaders within the BSG IBD guidelines group. He is also an associate editor of Alimentary Pharmacology & Therapeutics.

Consultant Specialist in IBD and intestinal failure, University Hospital of Wales, Cardiff ‐ Dr Hawthorne studied medicine at Queens’ College Cambridge, and went on to do his clinical training at the University of Oxford, qualifying in 1983. After doing an MD in Nottingham with Chris Hawkey, he took up a consultant post in Cardiff in 1995. His clinical interests are inflammatory bowel disease and intestinal failure. As well as developing the IBD services in Cardiff, he established and led the Cardiff Intestinal Failure service until 2017.
He is ex-chair of the BSG IBD section (2015-2018), led the writing of the BSG IBD guidelines (2019), and is chair of the Medical Research Grants committee for Crohn’s Colitis UK. He is a member of the IBD UK committee and has been involved in development of the UK IBD Standards 2019. He also sits on the IBD Wales committee. He is a director and board member of the IBD Registry co., representing the BSG. His research interests include clinical trials of immunosuppressive therapy in IBD, and the natural history of inflammatory bowel disease.

Professor Ailsa Hart is Consultant Gastroenterologist, St Mark’s Hospital and Sub-Dean of St Mark’s Hospital Academic Institute. She studied at Oxford University and was awarded a First Class Honours Degree. She achieved her PhD with Imperial College, funded by a Wellcome Trust Fellowship. She has published 2 books, over 200 papers, reviews and book chapters & supervised/ co-supervised over 20 higher degree students. She is currently on the Governing Board of the European Crohn’s and Colitis Organisation; is on the IBD Clinical Research Group Committee for the BSG; UK Patient and Public Involvement Lead for Gastroenterology; and on the Research Committee for the Crohn’s and Colitis UK charity.

James Lindsay is the Professor of Inflammatory Bowel Disease at Barts and the London School of Medicine and Dentistry, Queen Mary University of London and a Consultant Gastroenterologist at Barts Health NHS Trust. Along with a full multidisciplinary team he runs the adolescent and adult IBD service at The Royal London Hospital.
He is the Education Officer and a member of the Governing Board of the European Crohn’s and Colitis Organisation (ECCO). He is also the ECCO e-learning ambassador and past chair of the ECCO Education Committee. He has chaired working groups for the ECCO consensus on the management of Crohn’s disease and ulcerative colitis. He is the British Society of Gastroenterology (BSG) national societies representative to United European Gastroenterology and is a member of the International Organisation of IBD (IOIBD)
Professor Lindsay serves on the BSG IBD Clinical Trials Steering Group and is Chief Investigator for a series of investigator-led and commercial clinical trials in IBD. He leads the NIHR funded ASTIClite trial which will assess the efficacy, safety and mechanism of action of low intensity autologous stem cell transplantation in patients with refractory Crohn’s disease. In addition, he leads a program of translational science research.

Dr Nick Powell

Nick is an honorary Reader and consultant in Gastroenterology at King’s College London and Guy’s & St Thomas’ NHS Foundation Trust. His clinical and research interests focus on intestinal inflammation in the context of inflammatory bowel diseases (such as ulcerative colitis and Crohn’s disease), but also in gut inflammation resulting from certain treatments, such as immune checkpoint inhibitors. His lab is based in the Centre for Inflammation and Cancer Immunology (CIBCI) in the School of Immunology of Microbial Sciences, which is one of the biggest immunology communities in the UK.
His research group focuses on the molecular (transcription factors and microRNAs) and cellular (T-cells, dendritic cells and innate lymphoid cells) mechanisms responsible for mediating chronic intestinal inflammation. There is also a strong interest in understating anti-inflammatory mechanisms, including cellular mediators of immunosuppression, such as regulatory T-cells and mesenchymal stromal cells. His lab is also interested in understanding how cell-specific and tissue-specific transcriptional programmes disclose important information about disease pathogenesis, and how these signatures could be harnessed to predict outcomes in patients with gut inflammation.

Professor Tariq Iqbal

Tariq Iqbal is a hollow organ gastroenterologist based in Birmingham. He is involved in translational research and has set up the first licenced stool bank in the UK which provides FMT for the treatment of patients with C.difficile and for clinical trials across the UK. His main research interests involve iron/treatment of anaemia and in manipulation of the gut microbiome in IBD.

Dr Frances Humby

Frances Humby MRCP, PhD is a Senior Lecturer and Honorary Consultant in Clinical Rheumatology within the William Harvey Research Institute, Queen Mary University of London and Barts Health NHS Trust. Her research interests are translational and focused primarily on RA in particular on synovial pathobiological markers of prognosis in early disease and on the identification of synovial biomarkers of response/resistance to biologic drugs. She leads the RA biologics service at Barts Health NHS Trust and runs specialist clinics in early inflammatory arthritis and biologics. She is also lead for the EMR clinical trials unit.

Dr Fiona Eldridge

Principal Clinical Psychologist, Addenbrooke’s Hospital, Cambridge ‐ Dr Fiona Eldridge is an HPCP registered Principal Clinical Psychologist working at Addenbrooke’s Hospital Cambridge. She has extensive experience working with adults and young people in both mental health and latterly physical health care settings in a range of services. She currently works in Gastroenterology, specialising in IBD.
A particular area of interest is supporting services to imbed psychology within the team with a view to developing more integrated, person centred, models of care – improving outcomes for both the individual and the treating team. She has extensive post-qualification training in a number of therapeutic approaches including CBT, Acceptance and Commitment Therapy, Cognitive Analytic Therapy, Compassion Focussed therapy and Mindfulness Based Cognitive Therapy. She utilises these approaches in her individual work with patients but also in consultation, supervision and teaching. Her research interests include mood as input hypothesis in worry; rumination and psychological approaches in IBD treatment.

Nick is an honorary Reader and consultant in Gastroenterology at King’s College London and Guy’s & St Thomas’ NHS Foundation Trust. His clinical and research interests focus on intestinal inflammation in the context of inflammatory bowel diseases (such as ulcerative colitis and Crohn’s disease), but also in gut inflammation resulting from certain treatments, such as immune checkpoint inhibitors. His lab is based in the Centre for Inflammation and Cancer Immunology (CIBCI) in the School of Immunology of Microbial Sciences, which is one of the biggest immunology communities in the UK.
His research group focuses on the molecular (transcription factors and microRNAs) and cellular (T-cells, dendritic cells and innate lymphoid cells) mechanisms responsible for mediating chronic intestinal inflammation. There is also a strong interest in understating anti-inflammatory mechanisms, including cellular mediators of immunosuppression, such as regulatory T-cells and mesenchymal stromal cells. His lab is also interested in understanding how cell-specific and tissue-specific transcriptional programmes disclose important information about disease pathogenesis, and how these signatures could be harnessed to predict outcomes in patients with gut inflammation.

Tariq Iqbal is a hollow organ gastroenterologist based in Birmingham. He is involved in translational research and has set up the first licenced stool bank in the UK which provides FMT for the treatment of patients with C.difficile and for clinical trials across the UK. His main research interests involve iron/treatment of anaemia and in manipulation of the gut microbiome in IBD.

Frances Humby MRCP, PhD is a Senior Lecturer and Honorary Consultant in Clinical Rheumatology within the William Harvey Research Institute, Queen Mary University of London and Barts Health NHS Trust. Her research interests are translational and focused primarily on RA in particular on synovial pathobiological markers of prognosis in early disease and on the identification of synovial biomarkers of response/resistance to biologic drugs. She leads the RA biologics service at Barts Health NHS Trust and runs specialist clinics in early inflammatory arthritis and biologics. She is also lead for the EMR clinical trials unit.

Principal Clinical Psychologist, Addenbrooke’s Hospital, Cambridge ‐ Dr Fiona Eldridge is an HPCP registered Principal Clinical Psychologist working at Addenbrooke’s Hospital Cambridge. She has extensive experience working with adults and young people in both mental health and latterly physical health care settings in a range of services. She currently works in Gastroenterology, specialising in IBD.
A particular area of interest is supporting services to imbed psychology within the team with a view to developing more integrated, person centred, models of care – improving outcomes for both the individual and the treating team. She has extensive post-qualification training in a number of therapeutic approaches including CBT, Acceptance and Commitment Therapy, Cognitive Analytic Therapy, Compassion Focussed therapy and Mindfulness Based Cognitive Therapy. She utilises these approaches in her individual work with patients but also in consultation, supervision and teaching. Her research interests include mood as input hypothesis in worry; rumination and psychological approaches in IBD treatment.

Professor Kevin Whelan

Kevin Whelan is the Professor of Dietetics and Head of the Department of Nutritional Sciences at King’s College London. He is a Principal Investigator leading a translational research programme exploring the effect of dietary interventions on the gut microbiota, nutritional status and quality of life in inflammatory bowel disease and other gastrointestinal disorders. He has published over 150 journal papers on the topics of fibre, probiotics, prebiotics, FODMAPs and food additives. He was a member of the International Life Sciences Institute Expert Panel on Prebiotics and was an expert member of the panels developing the NICE Quality Standards for Inflammatory Bowel Disease and the ECCO Topical Reviews of Diet in IBD.

Ms Rosie Campbell

Rosie is a 29 year old PA from Essex. She was diagnosed with Crohn’s Disease in 2003. She has already tried many different drugs on her journey with Crohn’s, and uncountable surgeries. With many hospital admissions along the way. She is a keen advocate for the disease, having worked on projects with Crohn’s and Colitis UK, as well as frequently using social media to normalise IBD as a part of her everyday life. Rosie has experienced the differences in treatment at a paediatric clinic when first diagnosed at her local hospital that didn’t specialise in IBD. Then referred over to the Royal London which is where she has gone from Paediatrics, to adolescents, to adult clinics. Rosie has also attended clinics at St Marks hospital for specialised surgery to repair significant perianal disease.

Dr Alissa Walsh

Alissa Walsh is a Consultant Gastroenterologist at the John Radcliffe Hospital, Oxford. After completing her formal gastroenterology training in Australia Dr Walsh undertook a Clinical Fellowship in Inflammatory Bowel Diseases within the Oxford University Hospitals NHS Trust (2007-2008) and thereafter a National Health Medical Research Council fellowship in Australia (2009-2011). Alissa practiced in Sydney until 2015 at which stage she returned to Oxford where she has completed a DPhil in clinical medicine at the University of Oxford.

Alissa’s research interests have included IBD activity indices, faecal transplantation in UC and most recently real time data collection in patients with IBD.

Kevin Whelan is the Professor of Dietetics and Head of the Department of Nutritional Sciences at King’s College London. He is a Principal Investigator leading a translational research programme exploring the effect of dietary interventions on the gut microbiota, nutritional status and quality of life in inflammatory bowel disease and other gastrointestinal disorders. He has published over 150 journal papers on the topics of fibre, probiotics, prebiotics, FODMAPs and food additives. He was a member of the International Life Sciences Institute Expert Panel on Prebiotics and was an expert member of the panels developing the NICE Quality Standards for Inflammatory Bowel Disease and the ECCO Topical Reviews of Diet in IBD.

Rosie is a 29 year old PA from Essex. She was diagnosed with Crohn’s Disease in 2003. She has already tried many different drugs on her journey with Crohn’s, and uncountable surgeries. With many hospital admissions along the way. She is a keen advocate for the disease, having worked on projects with Crohn’s and Colitis UK, as well as frequently using social media to normalise IBD as a part of her everyday life. Rosie has experienced the differences in treatment at a paediatric clinic when first diagnosed at her local hospital that didn’t specialise in IBD. Then referred over to the Royal London which is where she has gone from Paediatrics, to adolescents, to adult clinics. Rosie has also attended clinics at St Marks hospital for specialised surgery to repair significant perianal disease.

Alissa Walsh is a Consultant Gastroenterologist at the John Radcliffe Hospital, Oxford. After completing her formal gastroenterology training in Australia Dr Walsh undertook a Clinical Fellowship in Inflammatory Bowel Diseases within the Oxford University Hospitals NHS Trust (2007-2008) and thereafter a National Health Medical Research Council fellowship in Australia (2009-2011). Alissa practiced in Sydney until 2015 at which stage she returned to Oxford where she has completed a DPhil in clinical medicine at the University of Oxford.

Alissa’s research interests have included IBD activity indices, faecal transplantation in UC and most recently real time data collection in patients with IBD.

PRESCRIBING INFORMATION

Job Code: UK-GAS-2000011 - Date of preparation: July 2022

cookiepopup

Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.